A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome

Kei Matsueda,Shigeru Harasawa,Michio Hongo,Nobuo Hiwatashi,D. Sasaki

A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome

2008

Kei Matsueda
Shigeru Harasawa
Michio Hongo
Nobuo Hiwatashi
D. Sasaki

Background: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder. Serotonin type 3 (5-HT3) receptor antagonist alosetron hydrochloride is indicated for wo

Keywords:

Receptor antagonist
Alosetron Hydrochloride
Serotonin
Ramosetron
Diabetes mellitus
Diarrhea
Ramosetron hydrochloride
Pharmacology
Endocrinology
Irritable bowel syndrome
Medicine
Internal medicine
gastrointestinal disorder

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations